Viewing Study NCT03435094


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-07-02 @ 10:09 PM
Study NCT ID: NCT03435094
Status: UNKNOWN
Last Update Posted: 2020-12-03
First Post: 2018-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
Sponsor: Labatec Pharma SA
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteoporosis, Postmenopausal View
Keywords: